Injective (INJ) surged 25% in 24 hours, gaining 30% over the past week and over 70% over the past month. The revenue/fully diluted value ratio of Injective exceeded that of Arbitrum by 20% and was over eight times higher than Ethereum’s, signaling valuation backed by real usage. The Gulf Labs partnership and bullish derivatives data supported short-term sentiment. Technically, a weekly close above $9.60 would confirm a bullish continuation, while the RSI at 72 reflects extremely strong buying momentum.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
